ARCH Venture Management, LLC Diversified Active

CIK: 0001274403 · Show all filings

Period: Q1 2020 (← Previous) (Next →)

Filing Date: May 6, 2020

Total Value ($000): $59,229 (100.0% shares, 0.0% debt)

Holdings (5)

— ADESTO TECHNOLOGIES CORP 35.5%

Value ($000) $20,998 Shares 1,876,511 Est. Cost $8.50 Unrealized —

— SYROS PHARMACEUTICALS INC 30.7%

Value ($000) $18,168 Shares 3,063,817 Est. Cost $10.38 Unrealized —

— RUBIUS THERAPEUTICS INC 19.7%

Value ($000) $11,652 Shares 2,618,351 Est. Cost $16.08 Unrealized —

— CHIASMA INC 7.4%

Value ($000) $4,368 Shares 1,196,776 Est. Cost $3.11 Unrealized —

KURA KURA ONCOLOGY INC 6.8%

Value ($000) $4,043 Shares 406,307 Est. Cost $13.25 Unrealized -13.6%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	ADESTO TECHNOLOGIES CORP	1,876,511	$20,998	35.5%	$8.50	—	COM	00687D101
—	SYROS PHARMACEUTICALS INC	3,063,817	$18,168	30.7%	$10.38	—	COM	87184Q107
—	RUBIUS THERAPEUTICS INC	2,618,351	$11,652	19.7%	$16.08	—	COM	78116T103
—	CHIASMA INC	1,196,776	$4,368	7.4%	$3.11	—	COM	16706W102
KURA	KURA ONCOLOGY INC	406,307	$4,043	6.8%	$13.25	-13.6%	COM	50127T109